vs
Side-by-side financial comparison of Shake Shack Inc. (SHAK) and Bio-Techne (TECH). Click either name above to swap in a different company.
Shake Shack Inc. is the larger business by last-quarter revenue ($400.5M vs $295.9M, roughly 1.4× Bio-Techne). Bio-Techne runs the higher net margin — 12.8% vs 3.0%, a 9.9% gap on every dollar of revenue. On growth, Shake Shack Inc. posted the faster year-over-year revenue change (21.9% vs -6.4%). Over the past eight quarters, Shake Shack Inc.'s revenue compounded faster (17.4% CAGR vs 4.2%).
Shake Shack is an American multinational fast casual restaurant chain based in New York City. It started out as a hot dog cart inside Madison Square Park in 2001, and its popularity steadily grew. In 2004, it received a permit to open a permanent kiosk within the park, expanding its menu from New York–style hot dogs to one with hamburgers, hot dogs, fries and its namesake milkshakes.
Bio-Techne Corporation is an American life sciences company that develops, manufactures and sells life science reagents, instruments and services for the research, diagnostic, and bioprocessing markets.
SHAK vs TECH — Head-to-Head
Income Statement — Q4 FY2025 vs Q2 FY2026
| Metric | | |
|---|---|---|
| Revenue | $400.5M | $295.9M |
| Net Profit | $11.8M | $38.0M |
| Gross Margin | — | 64.6% |
| Operating Margin | 4.7% | 18.4% |
| Net Margin | 3.0% | 12.8% |
| Revenue YoY | 21.9% | -6.4% |
| Net Profit YoY | 35.8% | 68.3% |
| EPS (diluted) | $0.28 | $0.24 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $400.5M | $295.9M | ||
| Q3 25 | $367.4M | — | ||
| Q2 25 | $356.5M | $317.0M | ||
| Q1 25 | $320.9M | $316.2M | ||
| Q4 24 | $328.7M | $297.0M | ||
| Q3 24 | $316.9M | $289.5M | ||
| Q2 24 | $316.5M | $306.1M | ||
| Q1 24 | $290.5M | $303.4M |
| Q4 25 | $11.8M | $38.0M | ||
| Q3 25 | $12.5M | — | ||
| Q2 25 | $17.1M | $-17.7M | ||
| Q1 25 | $4.2M | $22.6M | ||
| Q4 24 | $8.7M | $34.9M | ||
| Q3 24 | $-10.2M | $33.6M | ||
| Q2 24 | $9.7M | $40.6M | ||
| Q1 24 | $2.0M | $49.1M |
| Q4 25 | — | 64.6% | ||
| Q3 25 | — | — | ||
| Q2 25 | — | 62.7% | ||
| Q1 25 | — | 67.9% | ||
| Q4 24 | — | 65.3% | ||
| Q3 24 | — | 63.2% | ||
| Q2 24 | — | 66.4% | ||
| Q1 24 | — | 67.4% |
| Q4 25 | 4.7% | 18.4% | ||
| Q3 25 | 5.0% | — | ||
| Q2 25 | 6.3% | -7.5% | ||
| Q1 25 | 0.9% | 12.2% | ||
| Q4 24 | 3.1% | 16.0% | ||
| Q3 24 | -5.7% | 13.8% | ||
| Q2 24 | 3.4% | 15.0% | ||
| Q1 24 | 0.0% | 22.1% |
| Q4 25 | 3.0% | 12.8% | ||
| Q3 25 | 3.4% | — | ||
| Q2 25 | 4.8% | -5.6% | ||
| Q1 25 | 1.3% | 7.1% | ||
| Q4 24 | 2.6% | 11.7% | ||
| Q3 24 | -3.2% | 11.6% | ||
| Q2 24 | 3.1% | 13.3% | ||
| Q1 24 | 0.7% | 16.2% |
| Q4 25 | $0.28 | $0.24 | ||
| Q3 25 | $0.30 | — | ||
| Q2 25 | $0.41 | $-0.11 | ||
| Q1 25 | $0.10 | $0.14 | ||
| Q4 24 | $0.22 | $0.22 | ||
| Q3 24 | $-0.26 | $0.21 | ||
| Q2 24 | $0.23 | $0.26 | ||
| Q1 24 | $0.05 | $0.31 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $360.1M | $172.9M |
| Total DebtLower is stronger | $247.7M | $260.0M |
| Stockholders' EquityBook value | $525.3M | $2.0B |
| Total Assets | $1.9B | $2.5B |
| Debt / EquityLower = less leverage | 0.47× | 0.13× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $360.1M | $172.9M | ||
| Q3 25 | $357.8M | — | ||
| Q2 25 | $336.8M | $162.2M | ||
| Q1 25 | $312.9M | $140.7M | ||
| Q4 24 | $320.7M | $177.5M | ||
| Q3 24 | $310.9M | $187.5M | ||
| Q2 24 | $304.4M | $152.9M | ||
| Q1 24 | $284.8M | $145.3M |
| Q4 25 | $247.7M | $260.0M | ||
| Q3 25 | $247.5M | — | ||
| Q2 25 | $247.2M | $346.0M | ||
| Q1 25 | $246.9M | $330.0M | ||
| Q4 24 | $246.7M | $300.0M | ||
| Q3 24 | $246.4M | $300.0M | ||
| Q2 24 | $246.2M | $319.0M | ||
| Q1 24 | $245.9M | $389.0M |
| Q4 25 | $525.3M | $2.0B | ||
| Q3 25 | $509.0M | — | ||
| Q2 25 | $494.1M | $1.9B | ||
| Q1 25 | $473.3M | $2.0B | ||
| Q4 24 | $470.0M | $2.1B | ||
| Q3 24 | $456.1M | $2.1B | ||
| Q2 24 | $462.4M | $2.1B | ||
| Q1 24 | $446.4M | $2.0B |
| Q4 25 | $1.9B | $2.5B | ||
| Q3 25 | $1.8B | — | ||
| Q2 25 | $1.8B | $2.6B | ||
| Q1 25 | $1.7B | $2.6B | ||
| Q4 24 | $1.7B | $2.7B | ||
| Q3 24 | $1.7B | $2.7B | ||
| Q2 24 | $1.7B | $2.7B | ||
| Q1 24 | $1.6B | $2.7B |
| Q4 25 | 0.47× | 0.13× | ||
| Q3 25 | 0.49× | — | ||
| Q2 25 | 0.50× | 0.18× | ||
| Q1 25 | 0.52× | 0.16× | ||
| Q4 24 | 0.52× | 0.14× | ||
| Q3 24 | 0.54× | 0.14× | ||
| Q2 24 | 0.53× | 0.15× | ||
| Q1 24 | 0.55× | 0.19× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $63.1M | — |
| Free Cash FlowOCF − Capex | $4.0M | — |
| FCF MarginFCF / Revenue | 1.0% | — |
| Capex IntensityCapex / Revenue | 14.8% | — |
| Cash ConversionOCF / Net Profit | 5.34× | — |
| TTM Free Cash FlowTrailing 4 quarters | $56.5M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $63.1M | — | ||
| Q3 25 | $63.0M | — | ||
| Q2 25 | $65.0M | $98.2M | ||
| Q1 25 | $31.2M | $41.1M | ||
| Q4 24 | $45.1M | $84.3M | ||
| Q3 24 | $41.9M | $63.9M | ||
| Q2 24 | $53.5M | $75.5M | ||
| Q1 24 | $30.7M | $81.0M |
| Q4 25 | $4.0M | — | ||
| Q3 25 | $23.7M | — | ||
| Q2 25 | $26.9M | $93.3M | ||
| Q1 25 | $1.9M | $31.0M | ||
| Q4 24 | $10.4M | $77.5M | ||
| Q3 24 | $7.1M | $54.7M | ||
| Q2 24 | $20.6M | $57.5M | ||
| Q1 24 | $-2.4M | $64.5M |
| Q4 25 | 1.0% | — | ||
| Q3 25 | 6.5% | — | ||
| Q2 25 | 7.5% | 29.4% | ||
| Q1 25 | 0.6% | 9.8% | ||
| Q4 24 | 3.2% | 26.1% | ||
| Q3 24 | 2.2% | 18.9% | ||
| Q2 24 | 6.5% | 18.8% | ||
| Q1 24 | -0.8% | 21.3% |
| Q4 25 | 14.8% | — | ||
| Q3 25 | 10.7% | — | ||
| Q2 25 | 10.7% | 1.5% | ||
| Q1 25 | 9.1% | 3.2% | ||
| Q4 24 | 10.6% | 2.3% | ||
| Q3 24 | 11.0% | 3.2% | ||
| Q2 24 | 10.4% | 5.9% | ||
| Q1 24 | 11.4% | 5.4% |
| Q4 25 | 5.34× | — | ||
| Q3 25 | 5.04× | — | ||
| Q2 25 | 3.79× | — | ||
| Q1 25 | 7.36× | 1.82× | ||
| Q4 24 | 5.18× | 2.42× | ||
| Q3 24 | — | 1.90× | ||
| Q2 24 | 5.54× | 1.86× | ||
| Q1 24 | 15.03× | 1.65× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
SHAK
Segment breakdown not available.
TECH
| Diagnostics And Spatial Biology | $81.2M | 27% |
| EMEA Excluding UK | $75.4M | 25% |
| Other | $42.4M | 14% |
| Instruments | $29.6M | 10% |
| APAC Excluding Greater China | $22.7M | 8% |
| Services | $22.3M | 8% |
| GB | $13.7M | 5% |
| Royalty | $8.5M | 3% |
